The authors finally suggested that loss or reduced expression of the genes for the BRCA1-A complex and of the NHEJ components Ku70/80, XRCC4, XLF, and LIG4 in ATM-deficient tumours could explain resistance to PARPi in some cases [33]. This evidence concerns the gene BRCA1 and neoplasm.